Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Breast 1

Conditions

Advanced Head and Neck Carcinoma 1

Interventions

Cisplatin 57 pembrolizumab 54 Cetuximab 43 Radiotherapy 35 Docetaxel 21 Radiotherapy, Intensity-Modulated 20 Paclitaxel 19 Nivolumab 18 Fluorouracil 18 Carboplatin 17 Radiation 14 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 Gemcitabine 8 Everolimus 8 Biopsy 8 Surgical Procedures, Operative 7 Oxaliplatin 7 Cyclophosphamide 7 durvalumab 6 avelumab 6 Erlotinib Hydrochloride 6 Capecitabine 6 spartalizumab 5 epacadostat 5 Surveys and Questionnaires 5 Platinum 5 Immunoglobulin G 5 Gefitinib 5 Dexamethasone 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Radiopharmaceuticals × Head & Neck × Clear all

NCT02325349 2022-07-19

MLAPOCHI

Assistance Publique - Hôpitaux de Paris

Phase 2 Terminated

Head & NeckThoracic

Advanced Head and Neck Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡